Personal information

Keywords

rheumatoid arthritis, spondyloarthritis

Countries

France

Activities

Collapse all

Works (45)

The history of ankylosing spondylitis/axial spondyloarthritis – what is the driving force of new knowledge?

Seminars in Arthritis and Rheumatism
2025-04 | Journal article
DOI: 10.1016/j.semarthrit.2024.152611
Contributors: Braun J․; Sieper J․; Dougados M․
Source: check_circle
Crossref

Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA study

RMD Open
2025-01 | Journal article
DOI: 10.1136/rmdopen-2024-004756
Contributors: Rodolfo Perez-Alamino; Hernan Maldonado-Ficco; Anna Moltó; Christian Waimann; José Maldonado-Cocco; Maxime Dougados; Robert Landewé; Désirée van der Heijde; Filip Van den Bosch
Source: check_circle
Crossref

Impact of pregnancy on sacroiliac imaging in women with axial spondyloarthritis: results of the analysis of the DESIR cohort

Scandinavian Journal of Rheumatology
2025-01-02 | Journal article
DOI: 10.1080/03009742.2024.2361993
Contributors: E Portier; M Dougados; A Ruyssen-Witrand; A Moltó
Source: check_circle
Crossref

Different disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years

RMD Open
2024-12 | Journal article
DOI: 10.1136/rmdopen-2024-004910
Contributors: Elodie Portier; Leslie Benattar; Matthieu Resche-Rigon; Maxime Dougados; Laure Gossec; Anna Molto
Source: check_circle
Crossref

Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study

Scandinavian Journal of Rheumatology
2024-12-16 | Journal article
DOI: 10.1080/03009742.2024.2424085
Contributors: JMS Drouet; C López-Medina; A Molto; B Granger; B Fautrel; C Gaujoux-Viala; U Kiltz; M Dougados; L Gossec
Source: check_circle
Crossref

When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat‐to‐Target Strategy Trial in Patients With Axial Spondyloarthritis

Arthritis Care & Research
2024-11 | Journal article
DOI: 10.1002/acr.25387
Contributors: Clementina López‐Medina; Filip van den Bosch; Désirée van der Heijde; Maxime Dougados; Anna Molto
Source: check_circle
Crossref

Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA study

Rheumatology
2024-10-03 | Journal article
DOI: 10.1093/rheumatology/keae536
Contributors: Hernán Maldonado-Ficco; Clementina López-Medina; Rodolfo Perez-Alamino; Christian A Waimann; José A Maldonado-Cocco; Anna Moltó; Maxime Dougados; Robert B M Landewé; Désirée van der Heijde; Filip van Den Bosch
Source: check_circle
Crossref

Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis

Annals of the Rheumatic Diseases
2024-10-02 | Journal article
DOI: 10.1136/ard-2024-225862
Contributors: Joeri Nicolaes; Evi Tselenti; Theodore Aouad; Clementina López-Medina; Antoine Feydy; Hugues Talbot; Bengt Hoepken; Natasha de Peyrecave; Maxime Dougados
Source: check_circle
Crossref

Que nous a appris la cohorte DESIR en 10 ans ?

Revue du Rhumatisme
2024-09 | Journal article
DOI: 10.1016/j.rhum.2024.09.010
Contributors: Maxime Dougados
Source: check_circle
Crossref

Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort

Annals of the Rheumatic Diseases
2024-07 | Journal article
DOI: 10.1136/ard-2023-225184
Contributors: Anna Molto; Clementina López-Medina; Alexandre Sepriano; Sofia Ramiro; Manouk de Hooge; Miranda van Lunteren; Victoria Navarro-Compán; Daniel Wendling; Maxime Dougados
Source: check_circle
Crossref

Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort

RMD Open
2024-07 | Journal article
DOI: 10.1136/rmdopen-2024-004400
Contributors: Clementina López-Medina; Anna Molto; Alexandre Sepriano; Sofia Ramiro; Anne Tournadre; Maxime Dougados
Source: check_circle
Crossref

Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study

Rheumatology
2024-07-01 | Journal article
DOI: 10.1093/rheumatology/kead503
Contributors: Helena Santos; Ana R Henriques; Pedro M Machado; Clementina Lopez-Medina; Maxime Dougados; Helena Canhão; Ana M Rodrigues; Fernando Pimentel-Santos
Source: check_circle
Crossref

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Annals of the Rheumatic Diseases
2024-05 | Journal article
DOI: 10.1136/ard-2023-225185
Contributors: Désirée van der Heijde; Anna Molto; Sofia Ramiro; Jürgen Braun; Maxime Dougados; Floris A van Gaalen; Lianne S Gensler; Robert D Inman; Robert B M Landewé; Helena Marzo-Ortega et al.
Source: check_circle
Crossref

Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception Cohort

Joint Bone Spine
2024-05 | Journal article
DOI: 10.1016/j.jbspin.2023.105678
Contributors: Maxime Dougados; Chris Serrand; Sandrine Alonso; Francis Berenbaum; Pascal Claudepierre; Bernard Combe; Laure Gossec; Adeline Ruyssen-Witrand; Alain Saraux; Daniel Wendling et al.
Source: check_circle
Crossref

Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort

The Journal of Rheumatology
2024-04 | Journal article
DOI: 10.3899/jrheum.2023-0933
Contributors: Elodie Portier; Sylvie Chevret; Anouk Walter-Petrich; Adeline Ruyssen-Witrand; Maxime Dougados; Anna Moltó
Source: check_circle
Crossref

Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients

Rheumatology International
2024-04-10 | Journal article
DOI: 10.1007/s00296-024-05576-7
Contributors: Juliette Drouet; Clementina López-Medina; Benjamin Granger; Bruno Fautrel; Robert B. M. Landewe; Anna Molto; Cécile Gaujoux-Viala; Uta Kiltz; Maxime Dougados; Laure Gossec
Source: check_circle
Crossref

Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study

RMD Open
2024-02 | Journal article
DOI: 10.1136/rmdopen-2023-003942
Contributors: Maxime Dougados; Audrey Lardy-Cléaud; Emilie Desfleurs; Pascal Claudepierre; Philippe Goupille; Adeline Ryussen-Witrand; Alain Saraux; Anne Tournadre; Daniel Wendling; Cédric Lukas
Source: check_circle
Crossref

Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study

RMD Open
2024-01 | Journal article
DOI: 10.1136/rmdopen-2023-003776
Contributors: Maria Llop; Jordi Gratacós; Mireia Moreno; Marta Arevalo Salaet; Joan Calvet; Antoni Berenguer-Llergo; Maxime Dougados; Anna Molto; Clementina López-Medina
Source: check_circle
Crossref

Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort

RMD Open
2023-12 | Journal article
DOI: 10.1136/rmdopen-2023-003587
Contributors: Imke Redeker; Robert Landewé; Désirée van der Heijde; Sofia Ramiro; Annelies Boonen; Maxime Dougados; Jürgen Braun; Uta Kiltz
Source: check_circle
Crossref

Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study

RMD Open
2023-07 | Journal article
DOI: 10.1136/rmdopen-2023-003179
Contributors: Haseeb Chaudhary; Clementina López-Medina; Muhammad Asim Khan; Maxime Dougados; Marina Magrey
Source: check_circle
Crossref

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Annals of the Rheumatic Diseases
2023-06 | Journal article
DOI: 10.1136/ard-2022-222784
Contributors: Daniel Aletaha; Andreas Kerschbaumer; Kastriot Kastrati; Christian Dejaco; Maxime Dougados; Iain B McInnes; Naveed Sattar; Tanja A Stamm; Tsutomu Takeuchi; Michael Trauner et al.
Source: check_circle
Crossref

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

Annals of the Rheumatic Diseases
2023-06 | Journal article
DOI: 10.1136/annrheumdis-2022-222747
Contributors: Victoria Navarro-Compán; Anne Boel; Annelies Boonen; Philip J Mease; Maxime Dougados; Uta Kiltz; Robert B M Landewé; Xenofon Baraliakos; Wilson Bautista-Molano; Praveena Chiowchanwisawakit et al.
Source: check_circle
Crossref

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Annals of the Rheumatic Diseases
2023-04 | Journal article
DOI: 10.1136/ard-2022-223595
Contributors: Désirée van der Heijde; Atul Deodhar; Xenofon Baraliakos; Matthew A Brown; Hiroaki Dobashi; Maxime Dougados; Dirk Elewaut; Alicia M Ellis; Carmen Fleurinck; Karl Gaffney et al.
Source: check_circle
Crossref

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

Annals of the Rheumatic Diseases
2023-04 | Journal article
DOI: 10.1136/ard-2022-223406
Contributors: Maxime Dougados; Christina Charles-Schoeman; Zoltán Szekanecz; Jon T Giles; Steven R Ytterberg; Deepak L Bhatt; Gary G Koch; Ivana Vranic; Joseph Wu; Cunshan Wang et al.
Source: check_circle
Crossref

Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment

RMD Open
2023-03 | Journal article
DOI: 10.1136/rmdopen-2022-002794
Contributors: Marie Vallier; Béatrice Segurens; Elise Larsonneur; Vincent Meyer; Stephanie Ferreira; Christophe Caloustian; Jean-François Deleuze; Maxime Dougados; Mathias Chamaillard; Corinne Miceli-Richard
Source: check_circle
Crossref

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)

RMD Open
2023-03 | Journal article
DOI: 10.1136/rmdopen-2022-002802
Contributors: Maxime Dougados; Julien Lucas; Emilie Desfleurs; Pascal Claudepierre; Philippe Goupille; Adeline Ruyssen-Witrand; Alain Saraux; Anne Tournadre; Daniel Wendling; Cédric Lukas
Source: check_circle
Crossref

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

Annals of the Rheumatic Diseases
2023-01 | Journal article
DOI: 10.1136/ard-2022-222259
Contributors: Christina Charles-Schoeman; Maya H Buch; Maxime Dougados; Deepak L Bhatt; Jon T Giles; Steven R Ytterberg; Gary G Koch; Ivana Vranic; Joseph Wu; Cunshan Wang et al.
Source: check_circle
Crossref

Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study

RMD Open
2022-12 | Journal article
DOI: 10.1136/rmdopen-2022-002696
Contributors: Marta Arevalo Salaet; Clementina López-Medina; Mireia Moreno; Victoria Navarro-Compan; Joan Calvet Fontova; Maria Llop; Maxime Dougados; Jordi Gratacós
Source: check_circle
Crossref

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

The Journal of Rheumatology
2022-10 | Journal article
DOI: 10.3899/jrheum.211075
Contributors: Emilce E. Schneeberger; Gustavo Citera; Dario Ponce de Leon; Annette E. Szumski; Kenneth Kwok; Mariel Cutri; Maxime Dougados
Source: check_circle
Crossref

A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases

RMD Open
2022-09 | Journal article
DOI: 10.1136/rmdopen-2022-002359
Contributors: Kastriot Kastrati; Daniel Aletaha; Gerd R Burmester; Eva Chwala; Christian Dejaco; Maxime Dougados; Iain B McInnes; Angelo Ravelli; Naveed Sattar; Tanja A Stamm et al.
Source: check_circle
Crossref

Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study

RMD Open
2022-09 | Journal article
DOI: 10.1136/rmdopen-2022-002514
Contributors: Diego Benavent; Dafne Capelusnik; Sofia Ramiro; Anna Molto; Clementina López-Medina; Maxime Dougados; Victoria Navarro-Compán
Source: check_circle
Crossref

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis

RMD Open
2022-09 | Journal article
DOI: 10.1136/rmdopen-2022-002478
Contributors: Maxime Dougados; Peter C Taylor; Clifton O Bingham, III; Lara Fallon; Yves Brault; Satrajit Roychoudhury; Lisy Wang; Meriem Kessouri
Source: check_circle
Crossref

Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST

RMD Open
2022-07 | Journal article
DOI: 10.1136/rmdopen-2021-002165
Contributors: Jürgen Braun; Uta Kiltz; Atul Deodhar; Tetsuya Tomita; Maxime Dougados; Rebecca Bolce; David Sandoval; Chen-Yen Lin; Jessica Walsh
Source: check_circle
Crossref

Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department

Rheumatology International
2022-05 | Journal article
DOI: 10.1007/s00296-021-05055-3
Contributors: Elodie Portier; Maxime Dougados; Anna Moltó
Source: check_circle
Crossref

Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort

RMD Open
2022-05 | Journal article
DOI: 10.1136/rmdopen-2021-002040
Contributors: Joanna Kedra; Alexandre Lafourcade; Bernard Combe; Maxime Dougados; David Hajage; Bruno Fautrel
Source: check_circle
Crossref

Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study

Rheumatology International
2022-04 | Journal article
DOI: 10.1007/s00296-022-05099-z
Contributors: Astrid Dauchez; Maxime Dougados; Mathilde Kemula; Elodie Regnier; Selim Aractingi; Anna Moltó
Source: check_circle
Crossref

Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France

RMD Open
2022-03 | Journal article
DOI: 10.1136/rmdopen-2021-002106
Contributors: Maxime Dougados; Julien Lucas; Emilie Desfleurs; Cédric Lukas; Alain Saraux; Anne Tournadre; Adeline Ruyssen-Witrand; Daniel Wendling; Philippe Goupille; Pascal Claudepierre
Source: check_circle
Crossref

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension

Rheumatology
2022-02-02 | Journal article
DOI: 10.1093/rheumatology/keab346
Contributors: Désirée van der Heijde; Maxime Dougados; Walter P Maksymowych; Gina Bergman; Sean P Curtis; Anjela Tzontcheva; Susan Huyck; George Philip; Joachim Sieper
Source: check_circle
Crossref

Root joint involvement in spondyloarthritis: a post hoc analysis from the international ASAS-PerSpA study

Rheumatology
2022-02-02 | Journal article
DOI: 10.1093/rheumatology/keab380
Contributors: Nelly Ziadé; Jean El Hajj; Joe Rassi; Sani Hlais; Clementina López-Medina; Sherif M Gamal; Bassel Elzorkany; Maxime Dougados; Xenofon Baraliakos
Source: check_circle
Crossref

Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort

RMD Open
2022-01 | Journal article
DOI: 10.1136/rmdopen-2021-001846
Contributors: Marion Pons; Sylvie Chevret; Karine Briot; Maria-Antonietta d’Agostino; Christian Roux; Maxime Dougados; Anna Molto
Source: check_circle
Crossref

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey

The Journal of Rheumatology
2021-12 | Journal article
DOI: 10.3899/jrheum.210206
Contributors: Anne Boel; Victoria Navarro-Compán; Annelies Boonen; Philip Mease; Uta Kiltz; Maxime Dougados; Robert Landewé; Désirée van der Heijde
Source: check_circle
Crossref

Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three‐Year Results From the ESPOIR Cohort

Arthritis Care & Research
2021-09 | Journal article
DOI: 10.1002/acr.24237
Contributors: Ricardo J. O. Ferreira; Bruno Fautrel; Alain Saraux; Cécile Gaujoux‐Viala; Anne‐Christine Rat; Francis Guillemin; José A. P. da Silva; Maxime Dougados; Laure Gossec
Source: check_circle
Crossref

Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort

Rheumatology International
2021-04 | Journal article
DOI: 10.1007/s00296-021-04791-w
Contributors: Bassel Elzorkany; Abir Mokbel; Sherif M. Gamal; Ihsane Hmamouchi; Maxime Dougados
Source: check_circle
Crossref

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Annals of the Rheumatic Diseases
2020-01 | Journal article
DOI: 10.1136/annrheumdis-2019-215882
Contributors: Victoria Furer; Christien Rondaan; Marloes W Heijstek; Nancy Agmon-Levin; Sander van Assen; Marc Bijl; Ferry C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha Crnkic Kapetanovic et al.
Source: check_circle
Crossref

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD

RMD Open
2019-09 | Journal article
DOI: 10.1136/rmdopen-2019-001041
Contributors: Victoria Furer; Christien Rondaan; Marloes Heijstek; Sander van Assen; Marc Bijl; Nancy Agmon-Levin; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha Crnkic Kapetanovic et al.
Source: check_circle
Crossref

Peer review (12 reviews for 4 publications/grants)

Review activity for Annals of the rheumatic diseases (8)
Review activity for Nature reviews. (1)
Review activity for RMD open. (2)
Review activity for The Lancet. (1)
How many people are using ORCID?